Overview of the immunomodulatory role of bacterial probiotic-derived peptidoglycan: from molecular insights to therapeutic application
Frontiers in Microbiology · 26.02.2026 · 17
DOI: 10.3389/fmicb.2026.1761985 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 26.02.2026. Verfasst von Omer Qutaiba B Allela und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Alnoor University, Mosul, Iraq. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Probiotics are well recognized for their ability to modulate host immune responses; however, growing evidence indicates that many of their beneficial effects are mediated by structural components rather than by viable microorganisms. Among these components, probiotic-derived peptidoglycan has emerged as a key immunologically active molecule with a critical role in regulating both innate and adaptive immunity. Although substantial experimental data exist regarding its underlying mechanisms, the context-dependent immunomodulatory and anti-inflammatory functions of peptidoglycan have not been comprehensively integrated. In this review, we provide an up-to-date and comprehensive overview of the molecular and cellular mechanisms that govern the immunoregulatory properties of probiotic-derived peptidoglycan. We first discuss the structural diversity and processing of peptidoglycan and their implications for host recognition via pattern-recognition receptors, particularly Toll-like receptor 2 (TLR2) and nucleotide-binding oligomerization domain proteins 1 and 2 (NOD1/2). We then critically evaluate current evidence supporting the therapeutic potential of probiotic-derived peptidoglycan in infectious diseases, inflammatory bowel disease (IBD), autoimmune disorders, allergic inflammation, and cancer. Collectively, these findings suggest that peptidoglycan holds considerable promise for the development of next-generation microbiota-based immunotherapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Alnoor University, Mosul, Iraq.
- Ahl Al Bayt University, Kerbala, Iraq.
- College of Pharmacy, National University of Science and Technology, Muscat, Iraq.
- Gilgamesh Ahliya University, Baghdad, Iraq.
- Department of Pharmacy, Al-Zahrawi University College, Karbala, Iraq.
- Pharmacy College, Al-Farahidi University, Baghdad, Iraq.
Zitieren
APA
Allela, O. Q. B., Shareef, A., Sameer, H. N., Yaseen, A., Athab, Z. H., & Adil, M. (2026). Overview of the immunomodulatory role of bacterial probiotic-derived peptidoglycan: from molecular insights to therapeutic application. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1761985
Vancouver
Allela OQB, Shareef A, Sameer HN, Yaseen A, Athab ZH, Adil M. Overview of the immunomodulatory role of bacterial probiotic-derived peptidoglycan: from molecular insights to therapeutic application. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1761985
BibTeX
@article{Allela2026,
author = {Allela, Omer Qutaiba B and Shareef, Abdulkareem and Sameer, Hayder Naji and Yaseen, Ahmed and Athab, Zainab H and Adil, Mohaned},
title = {Overview of the immunomodulatory role of bacterial probiotic-derived peptidoglycan: from molecular insights to therapeutic application},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1761985}
}
EUVIMED